产品详情
所在位置: 首页> 产品目录> 一抗>
  • 产品名称:anti-MetabotropicGlutamateReceptor1antibody(GlutamateReceptor,Metabotropic1)

  • 产品型号:
  • 产品厂商:国内供应2
  • 产品文档:
你添加了1件商品 查看购物车
简单介绍:
anti-MetabotropicGlutamateReceptor1antibody(GlutamateReceptor,Metabotropic1)
详情介绍:
Immunogen Synthetic peptide of human GRM1
Isotype IgG
Purification Antigen affinity purification
Alternative Name GRM1 (GRM1 Antibody Abstract)
Background L-glutamate is the major excitatory neurotransmitter in the central nervous system and activates both ionotropic and metabotropic glutamate receptors. Glutamatergic neurotransmission is involved in most aspects of normal brain function and can be perturbed in many neuropathologic conditions. The metabotropic glutamate receptors are a family of G protein-coupled receptors, that have been divided into 3 groups on the basis of sequence homology, putative signal transduction mechanisms, and pharmacologic properties. Group I includes GRM1 and GRM5 and these receptors have been shown to activate phospholipase C. Group II includes GRM2 and GRM3 while Group III includes GRM4, GRM6, GRM7 and GRM8. Group II and III receptors are linked to the inhibition of the cyclic AMP cascade but differ in their agonist selectivities. The canonical alpha isoform of the metabotropic glutamate receptor 1 gene is a disulfide-linked homodimer whose activity is mediated by a G-protein-coupled phosphatidylinositol-calcium second messenger system. Alternative splicing results in multiple transcript variants encoding distinct isoforms, some of which may have distinct functions.
Synonyms: GRM1A, mGlu1, GPRC1A, MGLUR1, SCAR13, MGLUR1A
Application Notes Optimal working dilution should be determined by the investigator.
Restrictions For Research Use only
Format Liquid
Handling Advice Avoid freeze / thaw cycles.
Storage -20 °C/-80 °C
Storage Comment Store at -20°C (regular) and -80°C (long term).
Supplier Images
Immunohistochemistry (IHC) image for anti-Glutamate Receptor, Metabotropic 1 (GRM1) antibody (ABIN2431473) Immunohistochemistry of Human ovarian cancer using GRM1 Polyclonal Antibody at diluti...